The horizontal transmission of Clostridium difficile in the hospital environment is difficult to establish. Current methods to detect C. difficile spores on surfaces are not quantitative, lack sensitivity, and are protracted. We propose a novel rapid method to detect and quantify C. difficile contamination on surfaces. Sponge swabbing was compared to contact plate sampling to assess the in vitro recovery of C. difficile ribotype 027 contamination (ϳ10 0 , 10 1 , or 10 2 CFU of spores) from test surfaces (a bed rail, a stainless steel sheet, or a polypropylene work surface). Sponge swab contents were concentrated by vacuum filtration, and the filter membrane was plated onto selective agar. The efficacy of each technique for the recovery of C. difficile from sites in the clinical environment that are touched at a high frequency was evaluated. Contact plates recovered 19 to 32% of the total contamination on test surfaces, whereas sponge swabs recovered 76 to 94% of the total contamination, and contact plates failed to detect C. difficile contamination below a detection C lostridium difficile infection (CDI) remains one of the most clinically important health care-associated infections and continues to burden health care services and finances (1, 2). The presentation of the disease can vary from mild diarrhea to severe colitis (3) and toxic dilatation that requires colectomy or may result in death. The use of proton pump inhibitors, residence in long-term-care facilities, and use of antibiotics are recognized risk factors (4, 5). However, the increasing incidence of communityacquired CDI suggests that other contributory factors may be responsible for the spread of the disease (6, 7). The horizontal transmission of CDI is implicated in patients with or without diarrhea, who may shed spores of C. difficile to contaminate their surrounding surfaces (8). Spores of C. difficile can persist on hospital surfaces for months (9), posing a risk of spreading to surfaces beyond the near patient environment, such as via the hands of patients, visitors, and health care workers (10).To reduce the risk of transmission, patients considered to be sources of CDI should be isolated upon presentation of symptoms of diarrhea, and an enhanced cleaning protocol should be implemented (11). Decontamination of surfaces in the clinical environment using a sporicide is recommended for C. difficile-positive cases only (11). However, patients may remain asymptomatic, even though they are excreting C. difficile (3), and will not prompt the implementation of infection control measures in the absence of diarrhea. Consequently, patients with asymptomatic cases of C. difficile disease may continue to contaminate the clinical environment unhindered unless a carrier status is diagnosed.Assessment of surfaces in the patient environment to monitor contamination levels and the persistence of C. difficile spores is not routinely performed. Current methods to sample surfaces for C. difficile contamination are not quantitative, have a low sensitivity, and req...